Nuvectis Pharma, Inc. Proceeds from Issuance of Private Placement
Nuvectis Pharma, Inc. (NVCT) reported Proceeds from Issuance of Private Placement of $15.88 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2024-03-05
- Nuvectis Pharma, Inc. proceeds from issuance of private placement for the quarter ending 2022-12-31 was $0.00.
- Nuvectis Pharma, Inc. proceeds from issuance of private placement for the quarter ending 2022-09-30 was $1.68M.
- Nuvectis Pharma, Inc. proceeds from issuance of private placement for fiscal 2022 was $15.88M.
| Period end | Proceeds from Issuance of Private Placement | Proceeds from Issuance of Private Placement as first filed | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.68M derived: sum of 2 quarters · filed 2024-03-05 | $15.88M 10-K · filed 2024-03-05 | |||
| 2022-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $15.88M 10-Q · filed 2023-11-08 | ||||
| 2022-07-29 | $14.30M 10-K · filed 2023-03-08 | $14.20M 10-Q · filed 2022-11-08 | ||||
| 2022-06-30 | $14.20M 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |